Skip to main content

Table 1 Characteristic of 30 patients

From: Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course

Age (year) 32-80 (mean 64)
Gender  
 Male 25
 Female 5
Histology  
 Clear cell 23
 Papillary 5
 Clear/Sarcomatoid 1
 Clear/Papillary 1
TKI treatment  
 Sunitinib 16
 Sorafenib 14
MSKCC classification  
 Favorable 1
 Intermediate 21
 Poor 8
Nephrectomy  
 Yes 22
 No 8
Prior treatment  
 Non 19
 IFN-α 9
 Sorafenib 3
 Chemotherapy 2